Startup Scout 19 Oct 2022
Neobe Therapeutics breaks down tumor defenses with bacteria
Many cancer patients cannot benefit from cancer immunotherapy because their tumors are protected from the immune system. Neobe Therapeutics’ bacterial…
Immunotherapy
- Latest Posts
News and Trends 12 Oct 2022
Agreement signed to advance therapy for autoimmune disease
HanAll Biopharma’s licensed partner, Harbour BioMed, has signed an exclusive sublicense agreement with CSPC NBP Pharmaceutical Co., Ltd for an…
News and Trends 11 Oct 2022
Accelerated application for drug to help immunodeficiency submitted by Pharming
A marketing authorization application (MAA) has been submitted by Dutch company Pharming Group, to the European Medicines Agency (EMA) for…
In Depth 11 Oct 2022
The biggest private biotech investments in September 2022
The companies Acelyrin, InnovaFeed and Arsenal Biosciences bagged the biggest biotech investments in September 2022, with insect protein and cell…
ADVERTISEMENT
News and Trends 3 Oct 2022
Estrella and TradeUP merge to become publicly traded company
Estrella Biopharma, Inc. and TradeUP Acquisition Corp. have entered into a definitive business combination agreement that will result in Estrella…
News and Trends 27 Sep 2022
Bioheng Biotech has positive CAR-T cell therapy results published in academic journal
Positive results from a phase 1 clinical study of RD13-01, an anti-CD7 universal CAR-T therapy product, have been published in…
Interview 27 Sep 2022
Natural killer cells: a thriving frontier in allogeneic cell therapy
Kai Pinkernell, chief medical officer at Glycostem, discusses how natural killer (NK) cell therapies could usher in off-the-shelf cancer immunotherapies.…
Sponsored by Biognosys
27 Sep 2022Using the power of proteomics to predict immunotherapy responses in melanoma and beyond
Next-generation proteomics has a vital role to play in the search for new biomarkers of immunotherapy response. Recent studies in…
News and Trends 26 Sep 2022
TILT and MSD working on immunotherapy trial for non-small cell lung cancer
TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, has signed a second clinical trial collaboration and supply agreement with…
News and Trends 26 Sep 2022
Kupando raises €13M in series A funding round led by Remiges Ventures
A company developing agonists that stimulate immune cells today (September 26) announced it has secured €13 million ($12.6 million) in…
Startup Scout 22 Sep 2022
Cartography Biosciences unearths cancer immunotherapy targets
Despite its meteoric growth in the last twenty years, cancer immunotherapy research is hamstrung by a lack of viable drug…
News and Trends 20 Sep 2022
Biopharma company Faron announces escalation data cancer treatment study
A clinical stage biopharma company has announced further dose escalation data from its phase 1/2 study looking at the safety…
News and Trends 20 Sep 2022
Collaboration to develop new glioblastoma combination therapy nets €1.06M
Dutch biotech CimCure B.V., French biotech company Covalab, Amsterdam UMC (The Netherlands) and the University of Zurich (Switzerland), have received…
News and Trends 20 Sep 2022
Regen BioPharma files patent on new RNA/DNA-based approach to cancer immunotherapy
Regen BioPharma, Inc. has filed a provisional patent application with the USPTO entitled "Dual Checkpoint Inhibitor Aptamer Based Therapeutics." The…
News and Trends 19 Sep 2022
Global consortium looks to develop breakthrough RNA-based anti-cancer immunotherapy
The Hadassah Cancer Research Institute (HCRI) at the Hadassah University Medical Center in Jerusalem, Israel, is to lead CanceRNA, a…
News and Trends 19 Sep 2022
Bugworks Research and Cytecare Cancer Hospitals to set up cancer research center
Bugworks Research Inc., a clinical stage biopharmaceutical company, and Cytecare Cancer Hospitals are set to collaborate by setting up a…
ADVERTISEMENT
Best in Biotech 13 Sep 2022
The five hottest private biotech companies in India
India is brimming with biotech companies and a young and skilled workforce. Here’s a quick glance at the private healthcare…
News and Trends 12 Sep 2022
PDC*line Pharma presents results from phase I/II trial
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, has…
Startup Scout 8 Sep 2022
Stratosvir is overcoming the viral immunotherapy delivery bottleneck
The U.K. startup Stratosvir is working to tackle the barriers to developing viral immunotherapies for cancer, including allowing intravenous delivery…
News and Trends 8 Sep 2022
OncoBone signs deals with three partners to work on bone metastases
OncoBone Ventures has signed cooperation framework agreements with three partners. The company is a U.K. start up biotech looking to…
